Ontology highlight
ABSTRACT:
SUBMITTER: Krishna Kumar Tiwari
PROVIDER: MODEL1909300004 | BioModels | 2019-09-30
REPOSITORIES: BioModels
Park Sang-Min SM Hwang Chae Young CY Cho Sung-Hwan SH Lee Daewon D Gong Jeong-Ryeol JR Lee Soobeom S Nam Sohee S Cho Kwang-Hyun KH
The FEBS journal 20190220 7
Cetuximab (CTX), a monoclonal antibody against epidermal growth factor receptor, is being widely used for colorectal cancer (CRC) with wild-type (WT) KRAS. However, its responsiveness is still very limited and WT KRAS is not enough to indicate such responsiveness. Here, by analyzing the gene expression data of CRC patients treated with CTX monotherapy, we have identified DUSP4, ETV5, GNB5, NT5E, and PHLDA1 as potential targets to overcome CTX resistance. We found that knockdown of any of these f ...[more]